<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Tumors of female reproductive system</journal-id><journal-title-group><journal-title xml:lang="en">Tumors of female reproductive system</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли женской репродуктивной системы</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-4098</issn><issn publication-format="electronic">1999-8627</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">617</article-id><article-id pub-id-type="doi">10.17650/1994-4098-2018-14-4-35-42</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>GYNECOLOGY. ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ГИНЕКОЛОГИЯ. ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Chemoembolization with HepaSpheres as a stage of comprehensive treatment for malignant pelvic tumors</article-title><trans-title-group xml:lang="ru"><trans-title>Применение гепасфер для химиоэмболизации злокачественных опухолей малого таза как этап комплексного лечения</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1031-9376</contrib-id><name-alternatives><name xml:lang="en"><surname>Kedrova</surname><given-names>A. G.</given-names></name><name xml:lang="ru"><surname>Кедрова</surname><given-names>А. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Obstetrics and Gynecology</p><p><italic>28 Orekhovyy Boulevard, Moscow 115682, </italic></p><p><italic>91 Volokolamskoe Shosse, Moscow 125371</italic></p><p/></bio><bio xml:lang="ru"><p><bold>Анна Генриховна Кедрова</bold></p><p><bold/>Кафедра акушерства и гинекологии<bold> </bold></p><p><italic>115682 Москва, Ореховый бульвар, 28, </italic></p><p><italic>125371 Москва, Волоколамское шоссе, 91</italic></p><p><bold/></p></bio><email>kedrova.anna@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lebedev</surname><given-names>D. P.</given-names></name><name xml:lang="ru"><surname>Лебедев</surname><given-names>Д. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>28 Orekhovyy Boulevard, Moscow 115682</italic></p></bio><bio xml:lang="ru"><p><italic>115682 Москва, Ореховый бульвар, 28</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Astakhov</surname><given-names>D. A.</given-names></name><name xml:lang="ru"><surname>Астахов</surname><given-names>Д. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>28 Orekhovyy Boulevard, Moscow 115682</italic></p></bio><bio xml:lang="ru"><p><italic>115682 Москва, Ореховый бульвар, 28</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kosyy</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Косый</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>28 Orekhovyy Boulevard, Moscow 115682</italic></p></bio><bio xml:lang="ru"><p><italic>115682 Москва, Ореховый бульвар, 28</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zabozlaev</surname><given-names>F. G.</given-names></name><name xml:lang="ru"><surname>Забозлаев</surname><given-names>Ф. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Clinical Laboratory Diagnostics and Pathological Anatomy</p><p><italic>28 Orekhovyy Boulevard, Moscow 115682, </italic></p><p><italic>91 Volokolamskoe Shosse, Moscow 125371</italic></p><p/></bio><bio xml:lang="ru"><p>Кафедра клинической лабораторной диагностики и патологической анатомии </p><p><italic>115682 Москва, Ореховый бульвар, 28, </italic></p><p><italic>125371 Москва, Волоколамское шоссе, 91</italic></p><p/></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ishchenko</surname><given-names>R. V.</given-names></name><name xml:lang="ru"><surname>Ищенко</surname><given-names>Р. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>28 Orekhovyy Boulevard, Moscow 115682</italic></p></bio><bio xml:lang="ru"><p><italic>115682 Москва, Ореховый бульвар, 28</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal Research and Clinical Center for Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ «Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства России» (ФНКЦ ФМБА России)</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Academy of Postgraduate Education, Federal Research and Clinical Center, Federal Medical and Biological Agency</institution></aff><aff><institution xml:lang="ru">Академии постдипломного образования ФГБУ ФНКЦ ФМБА России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-21" publication-format="electronic"><day>21</day><month>12</month><year>2018</year></pub-date><volume>14</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>35</fpage><lpage>42</lpage><history><date date-type="received" iso-8601-date="2019-02-21"><day>21</day><month>02</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-02-21"><day>21</day><month>02</month><year>2019</year></date></history><permissions><copyright-year>2018</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://ojrs.abvpress.ru/ojrs/article/view/617">https://ojrs.abvpress.ru/ojrs/article/view/617</self-uri><abstract xml:lang="en"><p>Genital bleeding poses a serious threat to patients with progressive locally advanced malignant tumors. Surgical treatment is often impossible in these patients; therefore, to achieve reliable hemostasis, the patients should undergo embolization of vessels feeding the tumor. Good results have been achieved by selective catheterization of pelvic arteries using chemoembolization with HepaSphere microspheres (Biosphere Medical, France) delivering the therapeutic agent to the tumor. Hydrophilicity of microspheres loaded with cytostatics and their biological compatibility with tissues ensure long-term therapeutic effect by controlling tumor growth. Pronounced hemostatic and antitumor effects of this treatment method have been confirmed by a morphological study. This study analyzes 38 patients that underwent chemoembolization with HepaSpheres loaded with doxorubicin or irinotecan, which allowed surgery and further treatment.</p></abstract><trans-abstract xml:lang="ru"><p>Кровотечения из половых путей остаются серьезной угрозой для жизни пациентов с прогрессирующими местно-распространенными злокачественными опухолями. Часто хирургическое лечение таких больных на первом этапе невозможно, и для достижения надежного гемостаза применяется метод эмболизации сосудов, питающих опухоль. Надежные результаты были достигнуты при использовании селективной катетеризации артерий таза с химиоэмболизацией микросферами HepaSphere (Biosphere Medical, Франция), депонирующими лекарство в самой опухоли. За счет гидрофильности и биологической совместимости с тканями микросфер, заполняемых цитостатиком, можно достигать длительного лекарственного эффекта, контролируя рост опухоли. Выраженные гемостатический и противоопухолевый эффекты данного этапа лечения подтверждены морфологическим исследованием. В статье приводится анализ 38 случаев, в которых химиоэмболизация гепасферами, насыщенными доксорубицином или иринотеканом, дала возможность выполнить радикальную операцию и продолжить комбинированное лечение.</p></trans-abstract><kwd-group xml:lang="en"><kwd>arterial chemoembolization</kwd><kwd>recurrent cervical and uterine cancer</kwd><kwd>recurrent uterine sarcoma</kwd><kwd>uterine artery embolization</kwd><kwd>HepaSphere</kwd><kwd>hemostasis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>артериальная химиоэмболизация</kwd><kwd>рецидивы рака шейки и тела матки</kwd><kwd>рецидив саркомы матки</kwd><kwd>эмболизация маточных артерий</kwd><kwd>HepaSphere</kwd><kwd>остановка кровотечения</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Guan Y.S., He Q., Wang M.Q. Transcatheter arterial chemoembolization: history for more than 30 years. ISRN Gastroenterol 2012;2012:480650. PMID: 22966466. DOI: 10.5402/2012/480650.</mixed-citation><mixed-citation xml:lang="ru">Guan Y.S., He Q., Wang M.Q. Transcatheter arterial chemoembolization: history for more than 30 years. ISRN Gastroenterol 2012;2012:480650. PMID: 22966466. DOI: 10.5402/2012/480650.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Shashi B.P., Gamanagatti S., Sreenivas V. et al. Trans-arterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma: experience from a tertiary care centre in India. Indian J Radiol Imaging 2011;21(2):113–20. PMID: 21799594. DOI: 10.4103/0971-3026.82294.</mixed-citation><mixed-citation xml:lang="ru">Shashi B.P., Gamanagatti S., Sreenivas V. et al. Trans-arterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma: experience from a tertiary care centre in India. Indian J Radiol Imaging 2011;21(2):113–20. PMID: 21799594. DOI: 10.4103/0971-3026.82294.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Kato T., Nemoto R., Mori H. et al. Transcatheter arterial chemoembolization of renal cell carcinoma with microencapsulated mitomycin C. J Urol 1981;125(1):19–24. PMID: 7463576.</mixed-citation><mixed-citation xml:lang="ru">Kato T., Nemoto R., Mori H. et al. Transcatheter arterial chemoembolization of renal cell carcinoma with microencapsulated mitomycin C. J Urol 1981;125(1):19–24. PMID: 7463576.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Seldinger S.I. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta Radiol 1953;39(5):368–76. PMID: 13057644.</mixed-citation><mixed-citation xml:lang="ru">Seldinger S.I. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta Radiol 1953;39(5):368–76. PMID: 13057644.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Negussie A.H., Dreher M.R., Carmen G.J. et al. Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization. J Mater Sci Mater Med 2015;26(6):198. PMID: 26105830. DOI: 10.1007/s10856-015-5530-3.</mixed-citation><mixed-citation xml:lang="ru">Negussie A.H., Dreher M.R., Carmen G.J. et al. Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization. J Mater Sci Mater Med 2015;26(6):198. PMID: 26105830. DOI: 10.1007/s10856-015-5530-3.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Massmann A., Rodt T., Marquardt S. et al. Transarterial chemoembolization (TACE) for colorectal liver metastases – current status and critical review. Langenbecks Arch Surg 2015;400(6):641–59. PMID: 26088872. DOI: 10.1007/s00423-015-1308-9.</mixed-citation><mixed-citation xml:lang="ru">Massmann A., Rodt T., Marquardt S. et al. Transarterial chemoembolization (TACE) for colorectal liver metastases – current status and critical review. Langenbecks Arch Surg 2015;400(6):641–59. PMID: 26088872. DOI: 10.1007/s00423-015-1308-9.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Tsubamoto H., Wada R., Kanazawa R. et al. Neoadjuvant transarterial chemoembolization (TACE) using cisplatin with the combination of dose-dense intravenous administration of paclitaxel for the locally advanced cervical adenocarcinoma. J Clin Oncol 2009;27(suppl):e16518. DOI: 10.1200/jco.2009.27.15_suppl.e16518.</mixed-citation><mixed-citation xml:lang="ru">Tsubamoto H., Wada R., Kanazawa R. et al. Neoadjuvant transarterial chemoembolization (TACE) using cisplatin with the combination of dose-dense intravenous administration of paclitaxel for the locally advanced cervical adenocarcinoma. J Clin Oncol 2009;27(suppl):e16518. DOI: 10.1200/jco.2009.27.15_suppl.e16518.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Martin R.C., Scoggins C.R., Schreeder M. et al. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis. Cancer 2015;121(20):3649–58. DOI: 10.1002/cncr.29534.</mixed-citation><mixed-citation xml:lang="ru">Martin R.C., Scoggins C.R., Schreeder M. et al. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis. Cancer 2015;121(20):3649–58. DOI: 10.1002/cncr.29534.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Toyama T., Nitta N., Ohta S. et al. Clinical trial of cisplatin-conjugated gelatin microspheres for patients with hepatocellular carcinoma. Jpn J Radiol 2012;30(1):62–8. DOI: 10.1007/s11604-011-0010-2.</mixed-citation><mixed-citation xml:lang="ru">Toyama T., Nitta N., Ohta S. et al. Clinical trial of cisplatin-conjugated gelatin microspheres for patients with hepatocellular carcinoma. Jpn J Radiol 2012;30(1):62–8. DOI: 10.1007/s11604-011-0010-2.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Tinelli A., Prudenzano R., Malvasi A. et al. Emergency endovascular nanopharmacologic treatment in advanced gynecological cancers. Int J Gynecol Cancer 2010;20(7):1250–5. PMID: 21224780. DOI: 10.1111/IGC.0b013e3181e4a68d.</mixed-citation><mixed-citation xml:lang="ru">Tinelli A., Prudenzano R., Malvasi A. et al. Emergency endovascular nanopharmacologic treatment in advanced gynecological cancers. Int J Gynecol Cancer 2010;20(7):1250–5. PMID: 21224780. DOI: 10.1111/IGC.0b013e3181e4a68d.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Babaeva N.А., Antonova I.B., Aleshikova O.I. et al. The role of the selective uterine artery chemoembolization in combination therapy of locally advanced cervical cancer. Doctor.Ru 2018;2(146):20–5.</mixed-citation><mixed-citation xml:lang="ru">Babaeva N.А., Antonova I.B., Aleshikova O.I. et al. The role of the selective uterine artery chemoembolization in combination therapy of locally advanced cervical cancer. Doctor.Ru 2018;2(146):20–5.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Pisco J.M., Martins J.M., Correia M.G. Internal iliac artery: embolization to control hemorrhage from pelvic neoplasms. Radiology 1989;172(2):337–9. PMID: 2748811. DOI: 10.1148/radiology.172.2.2748811.</mixed-citation><mixed-citation xml:lang="ru">Pisco J.M., Martins J.M., Correia M.G. Internal iliac artery: embolization to control hemorrhage from pelvic neoplasms. Radiology 1989;172(2):337–9. PMID: 2748811. DOI: 10.1148/radiology.172.2.2748811.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Yamashita Y., Harada M., Yamamoto H. et al. Transcatheter arterial embolization of obstetric and gynaecological bleeding: efficacy and clinical outcome. Br J Radiol 1994;67(798):530–4. PMID: 8032805. DOI: 10.1259/0007-1285-67-798-530.</mixed-citation><mixed-citation xml:lang="ru">Yamashita Y., Harada M., Yamamoto H. et al. Transcatheter arterial embolization of obstetric and gynaecological bleeding: efficacy and clinical outcome. Br J Radiol 1994;67(798):530–4. PMID: 8032805. DOI: 10.1259/0007-1285-67-798-530.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Mihmanli I., Cantasdemir M., Kantarci F. et al. Percutaneous embolization in the management of intractable vaginal bleeding. Arch Gynecol Obstet 2001;264(4):211–4. PMID: 11205712.</mixed-citation><mixed-citation xml:lang="ru">Mihmanli I., Cantasdemir M., Kantarci F. et al. Percutaneous embolization in the management of intractable vaginal bleeding. Arch Gynecol Obstet 2001;264(4):211–4. PMID: 11205712.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Yalvac S., Kayikcioglu F., Boran N. et al. Embolization of uterine artery in terminal stage cervical cancers. Cancer Invest 2002;20(5–6):754–8. PMID: 12197232.</mixed-citation><mixed-citation xml:lang="ru">Yalvac S., Kayikcioglu F., Boran N. et al. Embolization of uterine artery in terminal stage cervical cancers. Cancer Invest 2002;20(5–6):754–8. PMID: 12197232.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Yin Y.J., Li H.Q., Sheng X.G. et al. The treatment of pelvic locoregional recurrence of cervical cancer after radical surgery with intensity-modulated radiation therapy compared with conventional radiotherapy: a retrospective study. Int J Gynecol Cancer 2015;25(6):1058–65. DOI: 10.1097/IGC.0000000000000360.</mixed-citation><mixed-citation xml:lang="ru">Yin Y.J., Li H.Q., Sheng X.G. et al. The treatment of pelvic locoregional recurrence of cervical cancer after radical surgery with intensity-modulated radiation therapy compared with conventional radiotherapy: a retrospective study. Int J Gynecol Cancer 2015;25(6):1058–65. DOI: 10.1097/IGC.0000000000000360.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Tian Z.Z., Li S., Wang Y. et al. Investigation of uterine arterial chemoembolization and uterine arterial infusion chemotherapy for advanced cervical cancer before radical radiotherapy: a long-term follow-up study. Arch Gynecol Obstet 2014;290(1):155–62. PMID: 24573504. DOI: 10.1007/s00404-014-3166-z.</mixed-citation><mixed-citation xml:lang="ru">Tian Z.Z., Li S., Wang Y. et al. Investigation of uterine arterial chemoembolization and uterine arterial infusion chemotherapy for advanced cervical cancer before radical radiotherapy: a long-term follow-up study. Arch Gynecol Obstet 2014;290(1):155–62. PMID: 24573504. DOI: 10.1007/s00404-014-3166-z.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Malik S.N., Shams M. Role of uterine artery embolization in the management of cervical cancer: review article. J Cancer Sci Ther 2012;4:167–9. DOI: 10.4172/1948-5956.1000134.</mixed-citation><mixed-citation xml:lang="ru">Malik S.N., Shams M. Role of uterine artery embolization in the management of cervical cancer: review article. J Cancer Sci Ther 2012;4:167–9. DOI: 10.4172/1948-5956.1000134.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Nagata Y., Araki N., Kimura H. et al. Neoadjuvant chemotherapy by transcatheter arterial infusion method for uterine cervical cancer. J Vasc Interv Radiol 2000;11(3):313–9.</mixed-citation><mixed-citation xml:lang="ru">Nagata Y., Araki N., Kimura H. et al. Neoadjuvant chemotherapy by transcatheter arterial infusion method for uterine cervical cancer. J Vasc Interv Radiol 2000;11(3):313–9.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Shao W., Zhng F., Cong N. et al. Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma. J Oncol Lett 2014;8(5):2263–6. PMID: 25289106. DOI: 10.3892/ol.2014.2512.</mixed-citation><mixed-citation xml:lang="ru">Shao W., Zhng F., Cong N. et al. Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma. J Oncol Lett 2014;8(5):2263–6. PMID: 25289106. DOI: 10.3892/ol.2014.2512.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
